TIA Scores' Mortality Predictions and Recurrent TIA and Stroke Prediction
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSaglik Bilimleri Universitesi
About this trial
Our study adopts a prospective design. Our research aims to determine the significance of ABCD2, ABCD3-I, Canadian TIA Score, and NIHSS Score in predicting the likelihood of ischemic stroke within 30 days in patients presenting to the emergency department with transient ischemic attack (TIA)
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
patients over the age of 18 presenting to emergency department with symptoms of stroke and diagnosed with TIA will be enrolled to study and will be followed up for 30 days for recurrent TIA or stroke
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
300 Participants
are grouped into 1 trial groupGroup A: TIA group
Trial outcomes
Primary outcomes
1
recurrent TIA or stroke
recurrent TIA within 30 days of follow-up
Time frame
30 daysSponsors and contacts
Click on the lead sponsor to view all of their trials.
Saglik Bilimleri Universitesi
Lead sponsor
Ankara Etlik City Hospital
Collaborator
Source ClinicalTrials.gov